Botanical drug products approved as prescription drugs
STO-REC-STATNRSYQYT1 Official
4
United States · as of 3 Sep 2026
Botanical drug products approved as prescription drugs in United States stood at 4 as of 3 September 2026 (FDA).
- Publisher
- FDA
- Authority tier
- T1 Official
- Locator
- FDA Seeks Public Input to Advance Development of Botanical Drug Products
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
To date, four botanical products have been approved for marketing as prescription drugs through the FDA’s new drug application and biologics license application pathways.
Verbatim extraction verified: The figure 4 is directly attested in the quoted passage (FDA Seeks Public Input to Advance Development of Botanical Drug Products).
The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.
- APA
- U.S. Food and Drug Administration. (2026). FDA Seeks Public Input to Advance Development of Botanical Drug Products. Retrieved September 17, 2026, from https://www.fda.gov/news-events/press-announcements/fda-seeks-public-input-advance-development-botanical-drug-products. Via StatOrigin, https://statorigin.org/stat/stat_NRSYQY2AXZDY94AMEFRD5DCGKY
- MLA
- U.S. Food and Drug Administration. "FDA Seeks Public Input to Advance Development of Botanical Drug Products." 2026, https://www.fda.gov/news-events/press-announcements/fda-seeks-public-input-advance-development-botanical-drug-products. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_NRSYQY2AXZDY94AMEFRD5DCGKY.
- Chicago
- U.S. Food and Drug Administration. "FDA Seeks Public Input to Advance Development of Botanical Drug Products." 2026. https://www.fda.gov/news-events/press-announcements/fda-seeks-public-input-advance-development-botanical-drug-products. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_NRSYQY2AXZDY94AMEFRD5DCGKY.
- BibTeX
- @misc{fda2026botanical5dcgky, author = {{U.S. Food and Drug Administration}}, title = {FDA Seeks Public Input to Advance Development of Botanical Drug Products}, year = {2026}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_NRSYQY2AXZDY94AMEFRD5DCGKY}, note = {Original source: https://www.fda.gov/news-events/press-announcements/fda-seeks-public-input-advance-development-botanical-drug-products. Accessed September 17, 2026.} }
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Chain of Custody · Verification Audit
Primary Source
- Publisher
- U.S. Food and Drug Administration · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- FDA Seeks Public Input to Advance Development of Botanical Drug Products
- Type
- Press release
- Published
- —
- Locator
- FDA Seeks Public Input to Advance Development of Botanical Drug Products
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification & Integrity
- Audit status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Archival URI
- /stat/stat_NRSYQY2AXZDY94AMEFRD5DCGKY